PRO-DEX, INC. Accumulated Other Comprehensive Income
PRO-DEX, INC. (PDEX) had Accumulated Other Comprehensive Income of -$215.00 thousand as of 2021-06-30, per its 10-K filed 2021-09-09.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-09-09
- 2021-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$215.00K.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$144.00K.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$280.00K.
- 2020-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.69M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-06-30 | -$215.00K 10-K · filed 2021-09-09 |
| 2021-03-31 | -$144.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$280.00K 10-Q · filed 2021-02-04 |
| 2020-09-30 | -$1.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$1.59M 10-K · filed 2021-09-09 |
| 2020-03-31 | -$1.16M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $100.00K 10-Q · filed 2020-02-06 |
| 2019-09-30 | -$606.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$549.00K 10-K · filed 2020-09-10 |
| 2019-03-31 | -$316.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$349.00K 10-Q · filed 2019-02-07 |
| 2018-09-30 | $145.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$153.00K 10-K · filed 2019-09-12 |
| 2018-03-31 | -$31.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$90.00K 10-Q · filed 2018-02-08 |
| 2017-09-30 | -$76.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $33.00K 10-K · filed 2018-09-13 |
| 2016-12-31 | -$6.00K 10-Q · filed 2017-02-09 |
| 2014-12-31 | $316.00K 10-Q · filed 2015-02-10 |
| 2014-09-30 | $213.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $202.00K 10-K · filed 2015-09-17 |
| 2014-03-31 | $202.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $209.00K 10-Q · filed 2014-02-06 |
| 2013-09-30 | $61.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $5.00K 10-K · filed 2014-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |